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PURPOSE. To describe the evolution of retinal thickness in eyes
affected with acute anterior uveitis (AAU) in the course of
follow-up and to assess its correlation with severity of
inflammatory activity in the anterior chamber.
METHODS. 72 eyes (affected and fellow eyes) of 36 patients
presenting with HLA-B27related acute anterior uveitis were
included in a prospective, institutional, cohort study. Patients
were followed daily until beginning of resolution of inflamma-
tory activity and weekly thereafter. Optical coherence tomog-
raphy and laser flare photometry were performed at each visit.
Treatment consisted of topical corticosteroids. Main outcome
measures were retinal thickness of affected eyes, difference in
retinal thickness between affected and fellow eyes and their
evolution in time, association between maximal retinal
thickness, and initial laser flare photometry.
RESULTS. Difference in retinal thickness between affected and
fellow eyes became significant on average 7 days from baseline
and remained so throughout follow-up (P < 0.001). There was
a steep increase in retinal thickness of affected eyes, followed
by a progressive decrease after reaching a peak value. Maximal
difference in retinal thickness between affected and fellow
eyes was observed between 17 and 25 days from baseline and
exhibited a strong, positive correlation with initial laser flare
photometry values (P ¼ 0.015).
CONCLUSIONS. Retinal thickness in eyes affected with AAU
presents a steep increase over 3 to 4 weeks and then gradually
decreases. Severity of inflammation at baseline predicts the
amount of retinal thickening in affected eyes. A characteristic
pattern of temporal response of retinal anatomy to inflamma-
tory stimuli seems to arise. (Invest Ophthalmol Vis Sci. 2012;
53:6171–6177) DOI:10.1167/iovs.12-10026
HLA-B27–associated acute anterior uveitis (AAU) is animportant pathological entity in view of its high frequency
and associated morbidity. Younger patients at the productive
age range are more commonly affected; and, despite its overall
favorable prognosis, HLA-B27–associated AAU remains a
considerable public health concern, following a typically
recurrent natural history and engendering potentially vision-
threatening ocular complications, such as cystoid macular
edema (CME).1–3
In contrast to the development of florid macular edema,
subclinical retinal thickening in the context of AAU, although
long suspected by clinicians, has yet to be verified in a
prospective trial. The understanding of this phenomenon and
its evolution over time could shed light into the mechanisms of
other relevant clinical manifestations, such as the increased
susceptibility of carriers of the HLA-B27 molecule to develop
macular edema following ocular surgery.4
The purpose of this prospective study was to describe the
response of retinal anatomy to inflammatory stimuli over time
in the course of an episode of AAU. We particularly attempted
to demonstrate the presence of subclinical retinal thickening in
eyes of patients with HLA-B27–associated AAU when compared
to their fellow eyes, as well as to investigate the association of
this phenomenon with the severity of inflammatory activity in
the anterior chamber and its evolution in the course of follow-
up. A homogenous group of patients with AAU served as a
model for assessing evolution of retinal thickness in time in the
context of intraocular inflammation. Extrapolating from our
findings, meaningful hypotheses can be made as regards retinal
behavior over time in response to inflammatory stimulation of
various origins.
METHODS
We conducted a prospective study, screening for inclusion all patients
presenting to the emergency service of the Jules Gonin Eye Hospital
with typical nongranulomatous unilateral AAU over a 2-year period.
Initial evaluations included bilateral laser flare photometry and optical
coherence tomography (OCT) to obtain a macular map. A blood
sample was collected in search of HLA-B27 antigen, and patients were
recruited for the study after a 24-hour reflection period. All carriers of
the HLA-B27 antigen aged between 16 and 80 years were included in
the study, and their follow-up was thereafter undertaken by the uveitis
clinic. Exclusion criteria comprised: all other types of uveitis; suspicion
of any underlying ocular or systemic disease that can cause macular
thickening; cloudiness of refractive media interfering with accurate
OCT measurements; pre-existing retinal lesions, such as epiretinal
membrane; diabetic retinopathy; prior ocular surgery of any kind,
including cataract surgery. Patients with severe, persistent inflamma-
tion necessitating systemic corticosteroid and/or immunomodulatory
treatment or in whom accurate flare and OCT measurements could not
be obtained as early as on the second follow-up visit (day 2 from
baseline) were excluded from further study. Patients who missed more
than one follow-up visit were also excluded from subsequent statistical
analysis. As the study population was, by definition, made up of
carriers of the HLA-B27 antigen, patients with HLA-B27–associated
spondyloarthropathies were not excluded from the analysis.
All patients were initially managed with hourly topical corticoste-
roid drops (prednisolone acetate 1%) and scopolamine 1% three times a
day over a short period and adaptation to inflammatory activity in
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subsequent daily follow-up visits. Patients were followed daily until
manifest response to local treatment was observed (defined as a
decrease of two crosses in anterior chamber cells or anterior chamber
flare on slit-lamp examination or a decrease of more than 30% from
baseline in laser flare photometry) and weekly thereafter until
complete resolution of inflammatory activity. A further long-term
follow-up visit at 3 months and beyond from the beginning of follow-up
took place for all patients. At each visit a complete ophthalmic
examination was performed, including best-corrected visual acuity,
tonometry, biomicroscopy, and fundus examination. Bilateral laser flare
photometry and macular OCT were also performed by the same
observer (KB) at each follow-up visit.
OCT was performed using the Fast Macular Thickness Map protocol
on the Stratus OCT (Software version 3.0; Zeiss-Meditec, Dublin, CA).
The following retinal thickness values were obtained and recorded
from the Stratus OCT Fast Macular Map of each eye at every visit:
central 1-mm subfield, inner ring extending from 1 mm to 3 mm
around the central subfield and comprising four quadrants, and outer
ring extending from 3 mm to 6 mm around the inner ring and also
comprising four quadrants (Fig. 1). The outer ring was excluded from
the statistical analysis because frequent artifacts and insufficient
resolution precluded credible thickness measurements. Subclinical
retinal thickening was defined as a statistically significant difference in
retinal thickness between inflamed and fellow eyes; that was, however,
not clinically detectable on fundoscopy.
The effect of time on retinal thickness difference between the study
eye and the contralateral eye (study minus contralateral) was assessed
by random intercept mixed models with maximum likelihood
estimation. These models account for the fact that a subject’s data
repeated over time are correlated. Random intercept models assume
that individual specific regression lines are parallel, whereas the
individual specific intercepts vary randomly. To take into account the
nonlinear trajectory of retinal thickness over time, we used time (days)
and log(timeþ1) as independent variables in the regressions. The same
method was used to estimate the effect of time on retinal thickness of
the affected eye. A different regression was run for each OCT subfield.
For each OCT subfield, Pearson correlation coefficients were used to
assess the correlation between initial OCT thickness and initial
LogMAR and the correlation between final OCT thickness and final
LogMAR. Spearman rank correlation coefficients were used to assess
the correlation between initial flare value and the maximal retinal
thickness of the affected eye measured over time, since the flare values
did not follow normal distributions. Lowess regression (locally
weighted scatterplot smoothing) was used to estimate the time when
flare had decreased to 50% and 10% of the initial value. All analyses
were performed using the statistical package Stata, version 11.1
(StataCorp, College Station, TX).
Described research adhered to the tenets of the Declaration of
Helsinki. Informed consent was obtained from all participants after
explanation of the nature and possible consequences of the study.
Research was approved by the Ethics Committee/Institutional Review
Board of the University of Lausanne.
RESULTS
Fifty-two patients were diagnosed with HLA-B27–associated
AAU over a 2-year period and were enrolled in the study. Out of
these, 2 patients were excluded due to media opacities
interfering with OCT measurements, 1 patient because of
persistent, severe inflammation necessitating administration of
systemic corticosteroids, and 13 patients because of more than
one missed follow-up assessment. Three patients out of 36
(8.33%) had concomitant HLA-B27–related spondyloarthropa-
thies. There were 36 patients included in the statistical
analysis. The effect of time on retinal thickness difference
between affected and fellow eyes is presented in Table 1.
Analyses were repeated after exclusion of one patient whose
outlying values influenced the models (patient 32 presenting
florid CME), though emerging patterns of evolution in retinal
FIGURE 1. OCT scan (patient 5) at 3 weeks from the beginning of the
inflammatory episode. Retinal thickening of the affected eye (LE) is
evident for all OCT subfields included in the analysis (A1–A5),
compared to corresponding subfields from the contralateral, unin-
volved eye. A particular ring pattern of retinal thickening involving the
inner, perifoveal ring of OCT subfields can be identified.
TABLE 1. Effect of Time on Difference in Retinal Thickness between
Study and Fellow Eyes for Corresponding Areas on OCT
OCT
Subfield Predictors
All Subjects
Parameter 95% CI P *
A1 Time 0.26 0.39 to 0.14 <0.001
Log(timeþ1) 6.83 3.99 to 9.66 <0.001
Intercept 0.62 10.46 to 11.69 0.913
A2 Time 0.31 0.40 to 0.24 <0.001
Log(timeþ1) 6.35 4.70 to 8.00 <0.001
Intercept 5.79 0.75 to 12.32 0.083
A3 Time 0.36 0.44 to 0.28 <0.001
Log(timeþ1) 6.66 4.90 to 8.42 <0.001
Intercept 6.03 0.97 to 13.02 0.092
A4 Time 0.30 0.38 to 0.22 <0.001
Log(timeþ1) 6.41 4.68 to 8.13 <0.001
Intercept 4.24 1.96 to 10.44 0.18
A5 Time 0.32 0.38 to 0.25 <0.001
Log(timeþ1) 6.11 4.59 to 7.63 <0.001
Intercept 5.19 1.97 to 12.36 0.156
A2 to A5 Time 1.29 1.52 to 1.05 <0.001
Log(timeþ1) 25.47 20.23 to 30.70 <0.001
Intercept 21.38 3.74 to 46.50 0.095
A1 to A5 Time 1.49 1.83 to 1.14 <0.001
Log(timeþ1) 30.99 23.24 to 38.74 <0.001
Intercept 21.87 13.57 to 57.31 0.226
A1, central subfield; A2, superior inner ring subfield; A3, temporal
inner ring subfield; A4, inferior inner ring subfield; A5, nasal inner ring
subfield.
* Difference in retinal thickness is not statistically significant at
time 0 (intercept) for any OCT subfield, though it becomes so in the
course of follow-up in relation with time.
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thickness were not affected. For all OCT subfields, difference
in retinal thickness between affected and fellow eyes is not
statistically significantly different from zero at day 0 (see
intercepts in Table 1) but becomes significantly different in the
course of follow-up. Difference in retinal thickness evolves in a
statistically significant way in the course of follow-up (P <
0.001). Figure 2 depicts the evolution of observed values
(irregular line) and values estimated by the statistical model
(regular line) of retinal thickness difference for all OCT
subfields in the course of follow-up. As can be inferred, the
statistical model offers an adequate estimate of the actual
evolution of retinal thickness difference in time for the first 70
to 80 days from the beginning of follow-up. A characteristic
pattern of evolution of difference in retinal thickness between
affected and fellow eyes in the course of follow-up emerges for
all OCT subfields. Difference in retinal thickness presents a
steep increase over a period of 17 to 25 days (depending on
the OCT subfield) before reaching a peak value, followed by a
progressive decrease. The model allows for identifying the
exact value of retinal thickness difference between fellow eyes
for each individual day of follow-up. Starting from the seventh
day of follow-up, difference in retinal thickness steadily
exceeds 10 lm for all OCT subfields. As is obvious from
presented curves, there is a discrepancy between observed and
estimated values later than 70 to 80 days from the beginning of
the episode, with actual difference values stabilizing, whereas
those estimated by the statistical model present a continuous
diminishing trend.
The day from the beginning of follow-up at which the
difference in retinal thickness obtains a maximum value for
every OCT subfield is presented in Table 2 (highest point of
curves of estimated values). For the A1 subfield, the greatest
difference in retinal thickness between affected and fellow
eyes is observed on day 25 from the beginning of the follow-
up, whereas it ranges between days 17 and 21 for the other
OCT subfields. The same statistical model as above was applied
for describing the evolution in retinal thickness of the affected
FIGURE 2. Evolution of observed values (irregular line) and values estimated by the statistical model (regular line) of retinal thickness difference
(in lm) (with and without patient 32, presenting florid CME) for all OCT subfields in the course of follow-up.
TABLE 2. Day of Maximal Difference in Retinal Thickening between
Affected and Fellow Eyes from the Beginning of the Inflammatory
Episode
OCT Subfield
All Subjects,
d
Subject 32
Excluded, d*
A1 25 25
A2 19 19
A3 18 17
A4 18 21
A5 18 18
A2 to A5 19 19
A1 to A5 20 20
* Patient presenting florid CME.
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eye for all OCT subfields included in the analysis. Figure 3
depicts the evolution of observed values (irregular line) and
values estimated by the statistical model (regular line) of retinal
thickness of the affected eye for all OCT subfields in the course
of follow-up. The retinal thickness of the affected eyes presents
a characteristic pattern of evolution in the course of follow-up,
with a steep increase over the first 20 to 25 days (depending on
the OCT subfield) and a subsequent progressive decrease.
At baseline, retinal thickness was higher in the affected than
in the contralateral eye in 85.25% to 94.12% of subjects
depending on the OCT subfield, though this difference did not
reach statistical significance for any of the OCT areas. Zone A3
corresponding to the temporal subfield was less affected
(increased in 85.25% of cases at baseline), whereas the nasal
subfield was the most frequently affected in the inflamed eye
(increased in 94.12% of cases). The difference in retinal
thickness increased progressively during follow-up and became
universal between 17 and 25 days, when thickness difference
reached its maximum in the various OCT subfields.
Correlations between initial mean visual acuity (LogMAR)
and initial mean retinal thickness for all OCT subfields are
presented in Table 3. As is evident, patient 26 alone, suffering
from amblyopia in the affected eye, has an important effect on
obtained correlations, which lose any statistical significance
once the patient is excluded from the analysis. Correlations
between mean final visual acuity at 3 months and beyond from
the beginning of follow-up and mean final retinal thickness for
all OCT subfields are presented in Table 4. Once again, any
statistical significance fades once patient 26 is excluded from
the analysis.
Correlations between initial laser flare values and maximal
retinal thickness of the affected and fellow eyes are presented
in Table 5. Correlations are positive, statistically significant, and
quite strong (rho around 0.5) between initial flare value and
maximal retinal thickness of affected eyes for all OCT subfields.
Figure 4 portrays the evolution of mean laser flare values in
the course of follow-up. Mean initial laser flare estimated by
FIGURE 3. Evolution of observed values (irregular line) and values estimated by the statistical model (regular line) of retinal thickness of the
affected eye (in lm) (with and without patient 32, presenting florid CME) for all OCT subfields in the course of follow-up.
TABLE 3. Correlation between Initial Visual Acuity and Initial Mean
Retinal Thickness in the Affected Eye (with and without Patient 26)
OCT Subfield
All Subjects Subject 26 Excluded*
Rho P Rho P
A1 0.41 0.027 0.09 0.667
A2 0.41 0.027 0.22 0.264
A3 0.41 0.027 0.14 0.483
A4 0.38 0.041 0.18 0.350
A5 0.40 0.030 0.11 0.562
A2 to A5 0.42 0.023 0.18 0.363
A1 to A5 0.44 0.015 0.17 0.373
* Patient suffering from amblyopia (outlier).
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Lowess regression is 118.16 photon units/ms. This value is
reduced by 50% after 14 days (59.18 photon units/ms) and by
90% after 57 days (11.83 photon units/ms).
DISCUSSION
Posterior segment involvement in the context of HLA-B27–
associated AAU has been well established, although the
prevalence of posterior segment manifestations varies consid-
erably in relevant literature, ranging from 0% to 62%.4–10 The
most common findings reported include vitritis, retinal
vasculitis, papillitis, epiretinal membrane formation, and
CME. As regards the latter manifestation, Uy et al. found its
frequency in HLA-B27–associated AAU to be 13.7%.9 In the
present study, there was only one case of florid CME (1:36
patients, 2.8%), in a patient suffering from ankylosing
spondylitis (patient 32). The proportion of patients in our
series with concomitant HLA-B27–related spondyloarthropa-
thies is similar to that reported in a previous analysis by
Rosenbaum.11
Few studies have tackled the issue of subclinical retinal
thickening in AAU. These include a retrospective study by
Castellano, which demonstrates a statistically significant
difference in retinal thickness between the study and fellow
eyes for all OCT subfields,12 and the study by Traill, which
shows significant thickness asymmetry between eyes of
patients with typical unilateral AAU, as opposed to the control
group.13 Nevertheless, none of these studies incorporates in
their design a scheduled follow-up that would allow study of
the evolution of retinal thickness in the course of the disease
and its response to treatment. A difference in retinal thickness
between affected and fellow eyes was used to demonstrate that
retinal thickening of affected eyes was statistically significant,
thus not accounted for by physiologic variation, bearing in
mind that retinal thickness of fellow eyes is strongly correlated
under normal circumstances.14,15
An individualized statistical approach was employed in this
study, based on random intercept mixed models to approxi-
mate the clinical evolution of retinal thickness of the affected
eye and its difference between affected and fellow eyes. The
obtained curves show a striking homogeneity in the response
of all macular subfields to inflammatory stimuli, with thickness
asymmetry between affected and fellow eyes becoming
clinically significant with a time lag of 1 week on average
from baseline, presenting a steep increase over a period of 17
to 25 days, depending on the OCT subfield, and subsequently
decreasing more gradually after reaching a maximal value.
Although all OCT subfields included in the statistical analysis
presented statistically significant retinal thickening, the phe-
nomenon was more pronounced in the inner retinal ring
surrounding the foveal zone, especially on its nasal side. This
ring-like pattern of retinal thickening was also observed in the
studies by Castellano and DeLahitte,12,16 signifying a potential
increased susceptibility of this anatomical region to thickening
in response to inflammatory stimuli.
An important finding of the present study is the identifica-
tion of a time lag between the onset of inflammatory activity
and the point of maximal retinal thickening in the affected eye.
This phenomenon was suggested in the study by Castellano,
although a prospective study design was needed to confirm
it.12 This gradual, accumulative response of the retina to
inflammatory stimuli may also account for the established
presentation of CME in patients undergoing cataract surgery,
with an onset several weeks following the procedure. It seems
indeed that retinal response to inflammatory agents is not an
all or none phenomenon; rather, retinal thickening progres-
sively ensues in the course of an inflammatory episode, once
the compensatory activity of the retinal pigment epithelium
pump has been overwhelmed.17
As the graphical representation of our findings eloquently
demonstrates, there is a long-term persistence of minimal
subretinal thickening of the affected eye at 3 months and
beyond from baseline. This finding may suggest a chronic
alteration of retinal anatomy following an episode of inflam-
mation-related retinal thickening. Repeated inflammatory
episodes may have a cumulative effect, increasing the
susceptibility of the retina to thickening in response to
inflammatory stimuli, though this hypothesis cannot be
verified in the context of the present study design.
The use of laser flare photometry for the quantification of
anterior chamber inflammation is well established and devoid
of the subjectivity in measurements of anterior chamber flare
TABLE 4. Correlation between Final Visual Acuity and Final Mean
Retinal Thickness in the Affected Eye (with and without Patient 26)
OCT
Subfield
All Patients Subject 26 Excluded*
Rho P Rho P
A1 0.53 0.002 0.19 0.324
A2 0.23 0.222 0.04 0.832
A3 0.26 0.164 0.28 0.147
A4 0.15 0.415 0.23 0.226
A5 0.34 0.060 0.002 0.991
A2 to A5 0.26 0.154 0.19 0.362
A1 to A5 0.37 0.038 0.02 0.901
* Outlier.
TABLE 5. Correlation between Initial Flare Values and Maximal Retinal
Thickness of the Affected Eye, Fellow Eye, and Maximal Difference in
Retinal Thickness between Eyes (Spearman’s Correlation Coefficient)
OCT
Subfield
Affected
Eye
Contralateral
Eye
Difference
between Eyes
Rho P Rho P Rho P
A1 0.50 0.003 0.05 0.796 0.21 0.268
A2 0.47 0.005 0.01 0.972 0.14 0.466
A3 0.55 <0.001 0.04 0.816 0.16 0.400
A4 0.47 0.005 0.05 0.797 0.06 0.748
A5 0.41 0.017 0.02 0.918 0.05 0.748
A2 to A5 0.49 0.003 0.02 0.896 0.17 0.385
A1 to A5 0.54 0.001 0.05 0.789 0.04 0.815
FIGURE 4. Evolution of flare values in the course of follow-up. (Lines
pointing to time of 50% and 90% decrease in initial flare values.)
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and inflammatory cells by slit-lamp biomicroscopy.18–20 In the
study by de Ancos et al., peak flare values in HLA-B27–
associated AAU occurred at baseline, with mean initial values
of 160þ22 photon units/ms, whereas a 50% reduction of flare
was noted by day 2 of follow-up and a 90% reduction after day
8.21 In the present study, a different pattern of evolution in
flare values was observed, with a mean initial flare value of
118.16 photon units/ms and a reduction by 50% and 90% of the
initial value after 14 and 57 days, respectively.
The association between severity of inflammation in the
anterior chamber, as measured by anterior chamber cells, and
retinal thickening identified in the study by Castellano is
modest and limited to the outer ring of the OCT map.12 On the
other hand, in the study by De Lahitte et al. in patients with
juvenile idiopathic arthritis–associated chronic anterior uveitis,
the association between the degree of inflammation, as
measured by laser flare photometry, and retinal thickening is
not confirmed. That study, however, only examines mean
foveal thickness and does not consider perifoveal areas of the
OCT separately.16 Gonzales et al. identify a positive correlation
between increased flare values obtained by laser flare
photometry and presence of CME in patients with uveitis of
various origins,22 whereas in the study by Magone et al. a
significant correlation between extent of peripheral retinitis
and laser flare photometry readings in patients with CMV
retinitis is identified.23 In our study, the association between
laser flare photometry values and maximal retinal thickness of
the affected eye was confirmed for all OCT subfields included
in the statistical analysis.
A negative correlation between retinal thickness and visual
acuity has been identified in patients with uveitic macular
edema.24 In the study by Castellano et al., a moderate
correlation between visual acuity and retinal thickness of
subfields outside the foveal center is reported.12 In the present
study no statistically significant association could be identified
between visual acuity and retinal thickness either at baseline or
at the end of follow-up, following the exclusion of a single
patient suffering from amblyopia whose low visual acuity
disproportionately affected statistical associations. Given that
visual function in AAU is generally preserved and retinal
thickening in the patients included in the present study was
subclinical, we believe this study sample is unsuitable for
investigating the association between retinal thickness and
visual acuity.
Previous attempts to evaluate the effect of anterior chamber
inflammation on retinal thickness were not focused on any
particular cause of anterior uveitis. In the present study, only
patients bearing the HLA-B27 antigen were included, as an
increased susceptibility to the development of CME has been
attributed to this group of patients.4 Moreover, patients with
HLA-B27–associated AAU constitute a homogenous group with
distinct characteristics, suitable for assessing the effect of
intraocular inflammatory activity on retinal thickness. This
cohort of patients sharing a common inflammatory pattern
served as a model for studying the response of retinal anatomy
to inflammatory stimuli over time.
This study has certain limitations. The statistical model
employed is complex, aiming at accommodating both anatom-
ical and temporal evolution of retinal thickening in HLA-B27–
associated AAU. While obtained estimates are in good
agreement with observed values for the first 70 to 80 days of
follow-up, the model fails to describe the long-term evolution
of the observed phenomenon at 3 months and beyond. Curves
for observed values were obtained by locally weighted
scatterplot smoothing of individual values. Such curves are
less accurate in graphical regions where there are fewer data
points. Since our data were becoming scarcer with the length
of follow-up, the right ends of the observed curves are likely to
be inaccurate. This may partly explain the difference between
observed and model-estimated values at times longer than 80
days from baseline. Moreover, although observed and estimat-
ed curves show considerable overlap, predicted values are
marginally overestimated by the model. There was one patient
with florid macular edema included in the study, though
statistical analyses performed with and without this patient did
not yield significantly different results.
In conclusion, our study demonstrated statistically signifi-
cant, yet subclinical, retinal thickening of eyes affected by HLA-
B27–associated AAU for all OCT subfields included in the
statistical analysis. Retinal thickening of affected eyes, as well
as difference in retinal thickness between affected and fellow
eyes, remained significant throughout the follow-up period and
presented a characteristic pattern of evolution of steep
increase and then slower decrease until stabilization. Maximal
retinal thickness of affected eyes correlated significantly with
initial flare values, measured by automated flare photometry.
The temporal evolution of retinal thickening in the course of
an acute episode of HLA-B27–associated AUU may shed
exciting new light into the response of retinal structures to
inflammatory stimuli over time.
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